Nasdaq

Microinvasive Glaucoma Surgery with the OMNI® Surgical System is Associated with Diminished Diurnal IOP Fluctuations, a Significant, Independent Risk Factor for Glaucoma ...

12-Month OMNI data from the prospective, multicenter GEMINI clinical trial show statistically significant postoperative reductions in mean IOP and suppression of daily IOP fluctuations MENLO PARK, ...
The Daily Illini

Carle medical student introduces microinvasive glaucoma surgery lab

Bhargavee Gnana, third-year medical student at the Carle Illinois College of Medicine, created a new learning lab to help provide students with early hands-on experience with microinvasive glaucoma ...
Healio

BLOG: MIGS was born in a developing nation

Please provide your email address to receive an email when new articles are posted on . The widespread adoption of microinvasive glaucoma surgery has been one of the most exciting developments in ...
Business Insider

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery

MENLO PARK, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative, ...
Healio

BLOG: Good data sharing practices can streamline glaucoma referrals

Please provide your email address to receive an email when new articles are posted on . Send the surgeon pertinent progress notes, not the entire patient file. Also share meaningful comparison images.